SCHEMBL272091

SCHEMBL272091

Cc1cccc(-c2ccc(C(=O)O)c(C)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXRB P28702 3/20 0.57
AKR1C2 P52895 1/20 0.56
AKR1C1 Q04828 1/20 0.56
MCL1 Q07820 3/20 0.56
RXRA P19793 2/20 0.55
DHODH Q02127 2/20 0.51
RARB P10826 1/20 0.50
HSD17B1 P14061 1/20 0.49
HSD17B2 P37059 1/20 0.49
ACMSD Q8TDX5 2/20 0.49
HNF4A P41235 1/20 0.49
ACLY P53396 1/20 0.48
HCAR2 Q8TDS4 1/20 0.48
POLB P06746 2/20 0.47
MAPT P10636 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
KMO O15229 1/20 0.46
LDHA P00338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122517 0.87 ACMSD (0.63) RXRBMCL1RXRARARBACMSD
SCHEMBL29926573 0.87 ACMSD (0.63) RXRBMCL1RXRARARBACMSD
SCHEMBL13522888 0.87 ACMSD (0.63) RXRBMCL1RXRARARBACMSD
SCHEMBL29771992 0.87 RXRB (0.70) RXRBMCL1RXRARARBACMSD
SCHEMBL1498034 0.87 RXRB (0.70) RXRBMCL1RXRARARBACMSD
Hydrochloric Acid SCHEMBL4365452 0.85 RXRB (0.68) RXRBMCL1RXRARARBACMSD
Hydrochloric Acid SCHEMBL9150803 0.85 RXRB (0.68) RXRBMCL1RXRARARBACMSD
SCHEMBL6564981 0.84 HSD17B1 (0.59) RXRBAKR1C2AKR1C1MCL1RXRA
SCHEMBL8840571 0.83 MCL1 (0.65) RXRBAKR1C2AKR1C1MCL1RXRA
M-Xylene SCHEMBL3275795 0.83 CSNK2A1 (0.52) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748417-B2 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2014-06-10 US disclosed
US-8575363-B2 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2013-11-05 US disclosed
US-8530003-B2 Polybenzoxazole precursor, photosensitive resin composition using the same, and manufacturing method of semiconductor device FUJIFILM CORPORATION (JP) 2013-09-10 US disclosed
US-20130196970-A1 AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2013-08-01 US disclosed
US-20120115333-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2012-05-10 US disclosed
US-20120101081-A1 AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2012-04-26 US disclosed
US-8133550-B2 Good breaking elongation characteristics, achievable high sensitivity and high film remaining rate, little in pattern size fluctuation at the heating time after lithographic process, capable of stable pattern formation; manufacturing a semiconductor device FUJIFILM CORPORATION (JP) 2012-03-13 US disclosed
US-7368216-B2 Photosensitive resin composition and manufacturing method of semiconductor device using the same FUJIFILM CORPORATION (JP) 2008-05-06 US disclosed
US-20080076849-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2008-03-27 US disclosed
EP-1852743-A1 Method for manufacturing photosensitive resin composition and relief pattern using the same FUJIFILM Corporation (JP) 2007-11-07 EP disclosed
US-20070254243-A1 METHOD FOR MANUFACTURING PHOTOSENSITIVE RESIN COMPOSITION AND RELIEF PATTERN USING THE SAME FUJIFILM CORPORATION (JP) 2007-11-01 US disclosed
US-20070172753-A1 Photosensitive resin composition and manufacturing method of semiconductor device using the same FUJIFILM CORPORATION (JP) 2007-07-26 US disclosed
EP-1811340-A2 Photosensitive resin composition and manufacturing method of semiconductor device using the same Fujifilm Corporation (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130196970-A1 AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, MGLL RXRB 2719/4885AKR1C2 1150/4885AKR1C1 1098/4885
US-20120101081-A1 AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, MGLL RXRB 2719/4885AKR1C2 1150/4885AKR1C1 1098/4885
US-20120115333-A1 POLYBENZOXAZOLE PRECURSOR, PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE CD79B, BRIX1, SMARCB1 RXRB 110/4885AKR1C2 3944/4885AKR1C1 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.